Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Applied Nanotech Board Elects Paul Rocheleau Vice-Chairman

Abstract:
Applied Nanotech Holdings, Inc. (OTC BB: APNT) announced that Paul Rocheleau has been elected Vice-Chairman of the Company's Board of Directors. In his role as Vice-Chairman, Paul will take an increased role in guiding company activities, with a focus on helping monetize our intellectual property by exposing it to strategic users with the ability to bring product rapidly to market and generate revenue for the Company.

Applied Nanotech Board Elects Paul Rocheleau Vice-Chairman

Austin, TX | Posted on November 23rd, 2009

Mr. Rocheleau has extensive experience in the global materials and chemicals industry. He is currently Chairman of the Board and Chief Investment Officer of Virginia Biosciences Commercialization Center. Over the past three years, he provided strategic and financial advisory services for a range of technology and industrial companies as a Managing Director at Cary Street Partners, a regional investment banking firm based in Richmond, Virginia. Prior experience included positions as Senior VP and Chief Financial Officer of Albermarle Corporation, a $2.0 Billion NYSE listed chemical company, and 15 years, including three as CEO, with Albright & Wilson, PLC, a $1.2 billion multinational chemical company.

Mr. Rocheleau currently serves on the Board of Directors of NanoChemonics, a specialty nano- materials company and serves on the Advisory Board Apex Systems, a $400 million IT staffing company. He also is a Founding Trustee of the Virginia Commonwealth University School of Engineering, where he currently serves as President of the Foundation.

"Paul has become integrally involved with us as a strategic advisor," said Doug Baker, Chief Executive Officer of APNT. "His new perspective has been invaluable to us and his increased level of involvement will be very helpful to us as we continue to increase our revenue and move the company to profitability."

"I am excited by the wealth of opportunities in front of us," said Paul Rocheleau, Director of APNT. "I am looking forward to helping bring these revolutionary technologies to market."

"All of our Board Members are working harder than ever to make the company successful," said Dr. Robert Ronstadt, Chairman of APNT. "It is encouraging to see that Paul is willing to go above and beyond the call of duty. His background in strategy and financing of emerging technologies will be very helpful in the years ahead."

The Company also announced that its updated website is live today. Investors are invited to submit comments or suggestions related to the website through the investor contact information on the website, or through the contact information [below].

Safe Harbor Statement
This press release contains forward-looking statements that involve risks and uncertainties concerning our business, products, and financial results. Actual results may differ materially from the results predicted. More information about potential risk factors that could affect our business, products, and financial results are included in our annual report on Form 10-K for the fiscal year ended December 31, 2008, and in reports subsequently filed by us with the Securities and Exchange Commission ("SEC"). All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval System (EDGAR) at www.sec.gov or from our website listed above. We hereby disclaim any obligation to publicly update the information provided above, including forward-looking statements, to reflect subsequent events or circumstances.

####

About Applied Nanotech Holdings
Applied Nanotech Holdings, Inc. is a premier research and commercialization organization focused on solving problems at the molecular level. Its team of PhD level scientists and engineers work with companies and other organizations to solve technical impasses and create innovations that will create a competitive advantage. The business model is to license patents and technology to partners that will manufacture and distribute products using the technology. Applied Nanotech has over 250 patents or patents pending. APNT also possesses investments related to electronic digitized sign technology.

For more information, please click here

Contacts:
Doug Baker
Applied Nanotech Holdings, Inc.
248.391.0612

Copyright © Applied Nanotech Holdings

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Ultracold atom waves may shed light on rogue ocean killers: Rice quantum experiments probe underlying physics of rogue ocean waves April 27th, 2017

Looking for the quantum frontier: Beyond classical computing without fault-tolerance? April 27th, 2017

Metal nanoparticles induced visible-light photocatalysis: Mechanisms, applications, ways of promoting catalytic activity and outlook April 27th, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

Announcements

Ultracold atom waves may shed light on rogue ocean killers: Rice quantum experiments probe underlying physics of rogue ocean waves April 27th, 2017

Looking for the quantum frontier: Beyond classical computing without fault-tolerance? April 27th, 2017

Metal nanoparticles induced visible-light photocatalysis: Mechanisms, applications, ways of promoting catalytic activity and outlook April 27th, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

Patents/IP/Tech Transfer/Licensing

Forge Nano 2017: 1st Quarter Media Update April 20th, 2017

Making Batteries From Waste Glass Bottles: UCR researchers are turning glass bottles into high performance lithium-ion batteries for electric vehicles and personal electronics April 19th, 2017

'Neuron-reading' nanowires could accelerate development of drugs for neurological diseases April 12th, 2017

Laser activated gold pyramids could deliver drugs, DNA into cells without harm: Microstructures create temporary pores in cells March 27th, 2017

Appointments/Promotions/New hires/Resignations/Deaths

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Francis Alexander Named Deputy Director of Brookhaven Lab's Computational Science Initiative February 16th, 2017

Nanobiotix appoints senior executive from pharmaceutical industry, as Chief Operating Officer: Oncology industry veteran to oversee operations and product commercialization February 8th, 2017

Dr Barbara Armbruster promoted to Worldwide Sales and Marketing Director for XEI Scientific September 27th, 2016

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project